Larvol Delta - aTyr-Pharma-Announces-Fourth-Positive-DSMB-Review-for-Efzofitimod-in-Phase-3-EFZOFIT-Study-in-Pulmonary-Sarcoidosis

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://www.globenewswire.com/news-release/2025/03/06/3038599/0/en/aTyr-Pharma-Announces-Fourth-Positive-DSMB-Review-for-Efzofitimod-in-Phase-3-EFZO-FIT-Study-in-Pulmonary-Sarcoidosis.html

Mar 6, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next